169 related articles for article (PubMed ID: 23740836)
1. Presenilin 1/γ-secretase modulates P-cadherin processing and influences cell adhesion in oral squamous cell carcinoma cell lines.
Bauer K; Gosau M; Reinders J; Oefner P; Reichert TE; Bauer R
Carcinogenesis; 2013 Nov; 34(11):2622-8. PubMed ID: 23740836
[TBL] [Abstract][Full Text] [Related]
2. P-cadherin controls the differentiation of oral keratinocytes by regulating cytokeratin 1/10 expression via C/EBP-beta-mediated signaling.
Bauer K; Gosau M; Bosserhoff A; Reichert T; Bauer R
Differentiation; 2012 Dec; 84(5):345-54. PubMed ID: 23142730
[TBL] [Abstract][Full Text] [Related]
3. Loss of adhesion-regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma.
Ghosh S; Munshi HG; Sen R; Linz-McGillem LA; Goldman RD; Lorch J; Green KJ; Jones JC; Stack MS
Cancer; 2002 Dec; 95(12):2524-33. PubMed ID: 12467066
[TBL] [Abstract][Full Text] [Related]
4. Slit-2 facilitates interaction of P-cadherin with Robo-3 and inhibits cell migration in an oral squamous cell carcinoma cell line.
Bauer K; Dowejko A; Bosserhoff AK; Reichert TE; Bauer R
Carcinogenesis; 2011 Jun; 32(6):935-43. PubMed ID: 21459757
[TBL] [Abstract][Full Text] [Related]
5. Presenilin 1/gamma-secretase is associated with cadmium-induced E-cadherin cleavage and COX-2 gene expression in T47D breast cancer cells.
Park CS; Kim OS; Yun SM; Jo SA; Jo I; Koh YH
Toxicol Sci; 2008 Dec; 106(2):413-22. PubMed ID: 18791180
[TBL] [Abstract][Full Text] [Related]
6. Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium.
Diamond ME; Sun L; Ottaviano AJ; Joseph MJ; Munshi HG
J Cell Sci; 2008 Jul; 121(Pt 13):2197-207. PubMed ID: 18544635
[TBL] [Abstract][Full Text] [Related]
7. Truncated P-cadherin is produced in oral squamous cell carcinoma.
Bauer R; Dowejko A; Driemel O; Bosserhoff AK; Reichert TE
FEBS J; 2008 Aug; 275(16):4198-210. PubMed ID: 18637117
[TBL] [Abstract][Full Text] [Related]
8. P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas.
Lo Muzio L; Pannone G; Mignogna MD; Staibano S; Mariggiò MA; Rubini C; Procaccini M; Dolci M; Bufo P; De Rosa G; Piattelli A
Histol Histopathol; 2004 Oct; 19(4):1089-99. PubMed ID: 15375751
[TBL] [Abstract][Full Text] [Related]
9. IFN-induced protein with tetratricopeptide repeats 2 inhibits migration activity and increases survival of oral squamous cell carcinoma.
Lai KC; Chang KW; Liu CJ; Kao SY; Lee TC
Mol Cancer Res; 2008 Sep; 6(9):1431-9. PubMed ID: 18819931
[TBL] [Abstract][Full Text] [Related]
10. P-cadherin expression reduced in squamous cell carcinoma of the oral cavity: an indicatior of poor prognosis.
Muñoz-Guerra MF; Marazuela EG; Fernández-Contreras ME; Gamallo C
Cancer; 2005 Mar; 103(5):960-9. PubMed ID: 15685613
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin downregulation and Twist overexpression since early stages of oral carcinogenesis.
de Freitas Silva BS; Yamamoto-Silva FP; Pontes HA; Pinto Júnior Ddos S
J Oral Pathol Med; 2014 Feb; 43(2):125-31. PubMed ID: 23772858
[TBL] [Abstract][Full Text] [Related]
12. Deregulated Bag-1 protein expression in human oral squamous cell carcinomas and lymph node metastases.
Hague A; Packham G; Huntley S; Shefford K; Eveson JW
J Pathol; 2002 May; 197(1):60-71. PubMed ID: 12081206
[TBL] [Abstract][Full Text] [Related]
13. Calsenilin regulates presenilin 1/γ-secretase-mediated N-cadherin ε-cleavage and β-catenin signaling.
Jang C; Choi JK; Na YJ; Jang B; Wasco W; Buxbaum JD; Kim YS; Choi EK
FASEB J; 2011 Dec; 25(12):4174-83. PubMed ID: 21852538
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.
Kato H; Uzawa K; Onda T; Kato Y; Saito K; Nakashima D; Ogawara K; Bukawa H; Yokoe H; Tanzawa H
Int J Oncol; 2006 Apr; 28(4):873-81. PubMed ID: 16525636
[TBL] [Abstract][Full Text] [Related]
16. miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma.
Chang KW; Chu TH; Gong NR; Chiang WF; Yang CC; Liu CJ; Wu CH; Lin SC
Oral Dis; 2013 Sep; 19(6):611-9. PubMed ID: 23231387
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Potential of N-Cadherin in Oral Squamous Cell Carcinoma via Immunohistochemical Methods.
Chandolia B; Rajliwal JP; Bajpai M; Arora M
J Coll Physicians Surg Pak; 2017 Aug; 27(8):475-478. PubMed ID: 28903838
[TBL] [Abstract][Full Text] [Related]
18. P-cadherin induces an epithelial-like phenotype in oral squamous cell carcinoma by GSK-3beta-mediated Snail phosphorylation.
Bauer K; Dowejko A; Bosserhoff AK; Reichert TE; Bauer RJ
Carcinogenesis; 2009 Oct; 30(10):1781-8. PubMed ID: 19654099
[TBL] [Abstract][Full Text] [Related]
19. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study.
Lo Muzio L; Campisi G; Farina A; Rubini C; Pannone G; Serpico R; Laino G; De Lillo A; Carinci F
BMC Cancer; 2005 Jun; 5():63. PubMed ID: 15967043
[TBL] [Abstract][Full Text] [Related]
20. Higher expression of WNT5A protein in oral squamous cell carcinoma compared with dysplasia and oral mucosa with a normal appearance.
Prgomet Z; Andersson T; Lindberg P
Eur J Oral Sci; 2017 Aug; 125(4):237-246. PubMed ID: 28603941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
